Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00395278 · ClinicalTrials.gov registry record
Development of Serologic Assays for Human Herpes Virus-8
A clinical trial of HIV Infection and Kaposi Sarcoma, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 394
- Enrollment target
- 1
- Study location
NCT00395278: Completed study of HIV Infection and Kaposi Sarcoma, sponsored by National Institutes of Health Clinical Center (CC).
NCT00395278 is a study of HIV Infection and Kaposi Sarcoma that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 394 participants, above the 237-participant average among 73 other HIV Infection trials with a reported enrollment target (66% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00395278, a study of HIV Infection and Kaposi Sarcoma, has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 394 participants
- Enrollment target
- 1
- Study location
Study Summary
Dr. Burbelo and colleagues have developed a technique for rapidly and quantitatively detecting antibody responses in sera to a variety of pathogens using recombinant proteins. We would like to apply this technique to develop an assay for detecting antibodies to HHV-8 (KSHV, the etiologic agents of Kaposi's sarcoma, an AIDS-defining condition). We initially plan to examine samples from patients with Kaposi's sarcoma, since all those patients are almost certainly infected with HHV-8. We are thus using samples from patients with previously diagnosed Kaposi's sarcoma. The samples in question are stored at the NCI FCRF repository operated by SAIC Frederick or in Rockville, MD.
Primary Outcome
Direction of antibodies to HHV8 proteins
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 394 participants |
| Start Date | 2006-10-30 |
| Est. Completion | 2020-12-10 |
What the finished NCT00395278 record still lists
NCT00395278 is an observational study that tracks outcomes without assigning an intervention. The registered 394 participants enrollment target is mid-sized for trials with a published cap, above the 237-participant average among 73 other HIV Infection trials with a reported enrollment target (66% higher).
The record links to 2 conditions, with HIV Infection appearing as the primary indexed condition, and to 0 interventions.
NCT00395278 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00395278 about?
NCT00395278 is a clinical study titled "Development of Serologic Assays for Human Herpes Virus-8". Dr. Burbelo and colleagues have developed a technique for rapidly and quantitatively detecting antibody responses in sera to a variety of pathogens using recombinant proteins. We would like to apply this technique to develop an assay for detecting antibodies to HHV-8 (KSHV, the etiologic agents of K...
What is the current status of trial NCT00395278?
This trial is currently completed. The enrollment target is 394 participants. The study started on 2006-10-30. Estimated completion is 2020-12-10.
What conditions does trial NCT00395278 study?
This clinical trial studies the following conditions: HIV Infection, Kaposi Sarcoma.
Who is sponsoring clinical trial NCT00395278?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00395278 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00395278's enrollment target sits among peer trials
394 10th of 73 higher than 64 of 73 other HIV Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
RECRUITING · Phase 2
-
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
RECRUITING · Phase 1
-
MAPS PrEP Van Study
RECRUITING · Phase 4
-
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
RECRUITING · NA
-
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
RECRUITING · NA
-
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06657924 · 394 participants · Phase 2
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
- NCT07225660 · 394 participants · NA
Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)
- NCT07207369 · 395 participants · Phase 3
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
- NCT05640999 · 393 participants · Phase 2
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI